New patent expiration for Salix Pharms drug RELISTOR
Drug Patent Watch
APRIL 7, 2024
Annual Drug Patent Expirations for RELISTOR Relistor is a drug marketed by Salix Pharms and Salix and is included in two NDAs. It is available from one supplier.
Sun.Apr 07, 2024
85 
Fitting of kinact and KI Values from Endpoint Pre-incubation IC50 Data
Covalent Modifiers
APRIL 7, 2024
Lavleen K. Mader and Jeffrey W. Keillor ACS Medicinal Chemistry Letters 2024 DOI: 10.1021/acsmedchemlett.4c00054 Experiments comprising a “pre-incubation” phase, where enzyme is incubated with inhibitor prior to the addition of assay substrate, are commonly used to evaluate covalent inhibitors, often via discontinuous or “endpoint” IC50 assays. However, due to the lack of mathematical tools to describe its biphasic time-dependent nature, this experiment has thus far been unable to provide kinact
New patent expiration for Insmed Inc drug ARIKAYCE KIT
Drug Patent Watch
APRIL 7, 2024
Annual Drug Patent Expirations for ARIKAYCE+KIT Arikayce Kit is a drug marketed by Insmed Inc and is included in one NDA. It is available from one supplier.
Which pharmaceutical companies have the most drug patents in Japan?
Drug Patent Watch
APRIL 7, 2024
This chart shows the pharmaceutical companies with the most patents in Japan.
From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Let's personalize your content